Complete Filing Data
Ultragenyx Pharmaceutical Inc. reported Net Income Loss of -$575.00 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ultragenyx Pharmaceutical Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$575.0M | -$569.0M | -$607.0M | -$707.4M | -$454.0M | -$186.6M | -$402.7M | -$197.6M | -$302.1M | -$245.9M | -$145.6M | -$59.8M | -$35.1M | -$16.3M |
| Cost of Revenue * | $1.1M | $1.0K | ||||||||||||
| Revenue * | $673.0M | $560.0M | $434.0M | $363.3M | $351.4M | $271.0M | $103.7M | $51.5M | $2.6M | $133.0K | ||||
| Research And Development Expense | $750.0M | $698.0M | $648.0M | $705.8M | $497.2M | $412.1M | $357.4M | $294.0M | $231.6M | $183.2M | $114.7M | $46.0M | $27.8M | $12.6M |
| Other Nonoperating Income Expense | $1.0M | -$5.0M | -$1.0M | -$1.6M | -$1.7M | $607.0K | -$787.0K | -$5.6M | $6.5M | -$1.6M | -$200.0K | -$3.6M | -$3.0M | -$350.0K |
| Operating Income Loss | -$535.0M | -$536.0M | -$569.0M | -$648.9M | -$381.7M | -$330.1M | -$424.2M | -$371.4M | -$328.9M | -$248.0M | -$147.7M | -$56.8M | -$32.3M | -$16.0M |
| Comprehensive Income Net Of Tax | -$573.0M | -$571.0M | -$599.0M | -$712.6M | -$456.1M | -$185.7M | -$402.2M | -$192.6M | -$308.7M | -$244.1M | -$146.3M | -$60.0M | -$35.1M | -$16.3M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0M | $0.00 | $8.0M | -$4.4M | -$1.5M | $101.0K | $463.0K | $78.0K | $35.0K | $451.0K | -$694.0K | -$185.0K | $11.0K | |
| Operating Expenses | $601.1M | $527.9M | $422.9M | $331.6M | $248.1M | $147.7M | $56.8M | $32.3M | $16.0M | |||||
| Other Comprehensive Income Loss Net Of Tax | $2.0M | -$2.0M | $8.0M | -$5.2M | -$2.1M | $836.0K | $486.0K | $5.0M | -$6.6M | $1.8M | -$694.0K | -$185.0K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $3.0M | -$2.0M | $0.00 | -$724.0K | -$550.0K | $735.0K | $23.0K | -$303.0K | -$10.1M | $1.3M | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$571.0M | -$567.0M | -$609.0M | -$701.7M | -$453.0M | -$185.4M | -$399.4M | -$197.1M | -$318.3M | -$245.8M | -$145.6M | -$59.8M | ||
| Income Tax Expense Benefit | $4.0M | $2.0M | -$2.0M | $5.7M | $1.0M | $1.2M | $3.3M | $514.0K | -$16.2M | $35.0K | ||||
| Selling General And Administrative Expense | $349.0M | $321.0M | $310.0M | $278.1M | $220.0M | $182.9M | $161.5M | $127.7M | $99.9M | $64.9M | $33.0M | |||
| Cost Of Sales | $109.0M | $77.0M | $45.0M | $28.3M | $16.0M | $6.1M | $9.0M | $1.1M | $1.0K | |||||
| Non Cash Interest Expense On Liability Related To Sale Of Future Royalties | $62.0M | $63.0M | $66.0M | $43.0M | $29.4M | $33.3M | $1.1M | |||||||
| Cost Of Sales And Operating Expenses | $1.21B | $1.10B | $1.00B | $1.01B | $733.1M | $601.1M | $527.9M | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$245.9M | -$145.6M | -$64.6M | -$50.3M | -$19.6M | |||||||||
| General And Administrative Expense | $64.9M | $33.0M | $10.8M | $4.5M | $3.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$180.4M | -$115.0M | -$151.1M | -$133.5M | -$131.6M | -$170.7M | -$159.6M | -$159.8M | -$164.0M | -$245.1M | -$158.2M | -$152.3M | -$73.0M | -$122.4M | -$136.1M | -$24.0M | -$68.8M | $25.3M | -$119.0M | -$93.8M | -$113.0M | -$99.2M | -$96.8M | -$87.8M | -$87.3M | -$52.7M | $30.3M | -$81.7M | -$79.2M | -$72.9M | -$68.3M | -$71.3M | -$64.9M | -$56.9M | -$52.8M | -$55.2M | -$39.2M | -$29.8M | -$21.4M | -$16.7M | -$15.8M | -$13.6M | -$13.6M | -$11.3M | -$8.4M | -$8.6M | -$6.7M |
| Cost of Revenue * | $766.0K | $452.0K | $273.0K | $141.0K | $225.0K | ||||||||||||||||||||||||||||||||||||||||||
| Revenue * | $159.9M | $166.5M | $139.3M | $139.5M | $147.0M | $108.8M | $98.1M | $108.3M | $100.5M | $90.7M | $89.3M | $79.9M | $81.6M | $87.0M | $99.4M | $91.5M | $81.5M | $61.7M | $36.3M | $35.6M | $25.8M | $24.1M | $18.2M | $16.3M | $11.8M | $12.8M | $10.7M | $2.4M | $198.0K | $5.0K | $111.0K | $17.0K | |||||||||||||||
| Research And Development Expense | $216.2M | $164.7M | $165.8M | $170.1M | $161.5M | $178.5M | $157.2M | $164.9M | $165.7M | $237.3M | $154.5M | $143.2M | $113.4M | $113.2M | $147.5M | $87.3M | $80.7M | $113.0M | $100.1M | $96.0M | $78.1M | $70.0M | $76.8M | $75.5M | $60.4M | $58.4M | $51.3M | $48.7M | $43.3M | $40.4M | $29.7M | $23.1M | $17.4M | $12.9M | $11.2M | $8.4M | $6.8M | $7.2M | $5.7M | ||||||||
| Other Nonoperating Income Expense | -$1.0M | $2.1M | $837.0K | $3.1M | -$1.8M | -$1.6M | -$699.0K | -$2.0M | $308.0K | -$1.1M | -$930.0K | $289.0K | -$415.0K | -$67.0K | -$795.0K | $547.0K | $217.0K | -$456.0K | -$153.0K | -$376.0K | -$412.0K | -$147.0K | -$496.0K | -$5.0M | $3.4M | $4.4M | $582.0K | -$46.0K | $159.0K | -$119.0K | $31.0K | -$101.0K | -$150.0K | -$185.0K | -$73.0K | -$3.4M | -$735.0K | -$343.0K | $12.0K | ||||||||
| Operating Income Loss | -$170.9M | -$107.9M | -$142.9M | -$132.0M | -$116.4M | -$165.3M | -$145.1M | -$148.0M | -$154.1M | -$225.1M | -$141.6M | -$136.6M | -$89.8M | -$82.8M | -$106.6M | -$50.3M | -$63.1M | -$120.7M | -$118.0M | -$112.5M | -$99.2M | -$89.6M | -$94.9M | -$96.5M | -$83.7M | -$78.4M | -$70.0M | -$65.8M | -$58.1M | -$53.6M | -$39.9M | -$30.1M | -$21.5M | -$15.8M | -$13.7M | -$10.3M | -$7.8M | -$8.2M | -$6.7M | ||||||||
| Comprehensive Income Net Of Tax | -$179.3M | -$114.9M | -$150.8M | -$131.5M | -$132.3M | -$171.8M | -$158.8M | -$159.0M | -$161.4M | -$246.4M | -$160.5M | -$157.5M | -$73.2M | -$122.3M | -$136.8M | -$69.1M | $28.1M | -$120.4M | -$113.3M | -$98.8M | -$96.3M | -$87.1M | -$52.4M | $35.0M | -$82.4M | -$77.3M | -$69.0M | -$65.1M | -$56.8M | -$51.8M | -$39.1M | -$29.9M | -$21.3M | -$15.9M | -$13.6M | -$13.7M | -$8.4M | -$8.7M | -$6.7M | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $13.0K | -$342.0K | -$90.0K | $3.5M | -$445.0K | -$1.2M | $1.1M | $576.0K | $2.5M | -$888.0K | -$1.6M | -$5.1M | -$12.0K | $73.0K | -$348.0K | -$645.0K | $2.7M | -$1.3M | -$92.0K | $377.0K | $356.0K | $183.0K | $67.0K | -$249.0K | $145.0K | -$51.0K | -$26.0K | -$212.0K | $149.0K | $960.0K | $170.0K | -$115.0K | $80.0K | -$70.0K | -$2.0K | -$57.0K | $63.0K | -$66.0K | |||||||||
| Operating Expenses | $169.8M | $206.0M | $187.6M | $131.8M | $124.8M | $157.0M | $130.0M | $143.8M | $136.6M | $117.4M | $106.6M | $101.4M | $107.7M | $107.2M | $99.2M | $83.9M | $78.4M | $70.0M | $70.6M | $65.9M | $58.1M | $53.6M | $56.2M | $39.9M | $30.1M | $21.5M | $16.9M | $15.8M | $13.7M | $10.3M | $9.5M | $7.8M | $8.2M | $6.7M | |||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $1.1M | $73.0K | $302.0K | $2.0M | -$664.0K | -$1.1M | $854.0K | $869.0K | $2.6M | -$1.3M | -$2.4M | -$5.2M | -$178.0K | $176.0K | -$633.0K | -$271.0K | $2.8M | -$1.4M | -$326.0K | $403.0K | $485.0K | $244.0K | $292.0K | $4.7M | -$3.2M | -$4.5M | -$674.0K | -$240.0K | $160.0K | $960.0K | $170.0K | -$115.0K | |||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $1.1M | $415.0K | $392.0K | -$1.5M | -$219.0K | $129.0K | -$249.0K | $293.0K | $144.0K | -$420.0K | -$731.0K | -$60.0K | -$166.0K | $103.0K | -$285.0K | $374.0K | $89.0K | -$49.0K | -$234.0K | $26.0K | $129.0K | $61.0K | $225.0K | -$289.0K | -$3.3M | -$4.4M | -$648.0K | -$28.0K | $11.0K | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$179.5M | -$114.0M | -$149.8M | -$133.2M | -$130.7M | -$170.2M | -$159.0M | -$159.1M | -$163.5M | -$238.8M | -$157.9M | -$151.8M | -$72.8M | -$122.0M | -$135.8M | -$68.5M | $25.7M | -$118.6M | -$112.7M | -$99.0M | -$96.5M | -$87.1M | -$52.6M | $30.3M | -$79.2M | -$72.9M | -$68.3M | -$64.9M | -$56.9M | ||||||||||||||||||
| Income Tax Expense Benefit | $873.0K | $947.0K | $1.3M | $303.0K | $858.0K | $455.0K | $650.0K | $732.0K | $495.0K | $6.3M | $302.0K | $558.0K | $182.0K | $463.0K | $379.0K | $313.0K | $415.0K | $409.0K | $293.0K | $213.0K | $216.0K | $247.0K | $102.0K | $39.0K | $4.0K | $14.0K | |||||||||||||||||||||
| Selling General And Administrative Expense | $86.6M | $86.6M | $87.8M | $80.4M | $80.6M | $78.2M | $74.9M | $81.4M | $76.6M | $69.8M | $68.1M | $67.3M | $53.9M | $53.4M | $53.3M | $42.1M | $42.3M | $47.5M | $41.0M | $39.8M | $38.8M | $31.1M | $30.7M | $31.4M | $23.5M | $20.0M | $18.7M | ||||||||||||||||||||
| Cost Of Sales | $28.0M | $23.0M | $28.7M | $21.0M | $21.3M | $17.5M | $11.0M | $9.9M | $12.3M | $8.6M | $8.3M | $6.1M | $4.2M | $3.1M | $5.2M | $2.3M | $1.8M | -$3.5M | $2.7M | $766.0K | $452.0K | $273.0K | |||||||||||||||||||||||||
| Non Cash Interest Expense On Liability Related To Sale Of Future Royalties | $14.1M | $14.0M | $14.3M | $15.7M | $16.0M | $15.8M | $17.7M | $15.4M | $15.6M | $14.5M | $6.1M | $6.6M | $8.7M | $8.5M | $8.4M | $8.6M | $8.4M | $8.1M | |||||||||||||||||||||||||||||
| Cost Of Sales And Operating Expenses | $330.8M | $274.4M | $282.2M | $271.5M | $263.4M | $274.2M | $243.1M | $256.3M | $254.6M | $315.8M | $230.9M | $216.6M | $171.5M | $169.8M | $206.0M | $131.8M | |||||||||||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$71.3M | -$64.9M | -$56.9M | -$52.8M | -$55.2M | -$39.2M | -$29.8M | -$21.4M | -$16.7M | -$15.8M | -$13.6M | -$18.4M | -$18.7M | -$12.6M | -$10.8M | -$8.2M | |||||||||||||||||||||||||||||||
| General And Administrative Expense | $23.5M | $20.0M | $18.7M | $17.2M | $14.7M | $13.2M | $10.2M | $7.0M | $4.1M | $3.0M | $2.4M | $2.0M | $999.0K | $1.0M | $1.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$80.0M | $255.0M | $275.0M | $352.0M | $922.6M | $1.15B | $653.8M | $608.9M | $383.5M | $474.0M | $531.1M | $184.9M | -$74.8M | -$27.0M | -$8.0M |
| Cash And Cash Equivalents At Carrying Value | $421.0M | $174.0M | $214.0M | $132.9M | $307.6M | $713.5M | $433.6M | $113.4M | $100.5M | $161.1M | $93.6M | $24.3M | $7.4M | $86.2M | $10.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $436.0M | $184.0M | $219.0M | $138.0M | $309.6M | $726.3M | $436.2M | $115.5M | $103.0M | $164.6M | $95.9M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.0M | $13.0M | $13.0M | -$2.7M | -$6.6M | -$848.0K | $6.2M | $2.6M | -$1.7M | -$4.8M | -$5.6M | -$3.6M | -$1.4M | ||
| Retained Earnings Accumulated Deficit | -$4.53B | -$3.96B | -$3.39B | -$2.78B | -$2.07B | -$1.62B | -$1.43B | -$1.03B | -$832.7M | -$530.5M | -$284.7M | -$139.0M | -$74.8M | ||
| Property Plant And Equipment Net | $244.0M | $266.0M | $290.6M | $259.7M | $141.2M | $73.5M | $44.3M | $20.0M | $21.8M | $17.1M | $7.4M | $3.0M | $1.3M | ||
| Other Assets Noncurrent | $60.0M | $63.0M | $57.7M | $48.3M | $20.6M | $8.8M | $3.5M | $3.5M | $3.4M | $1.8M | $595.0K | $774.0K | $2.6M | ||
| Liabilities Current | $384.0M | $344.0M | $280.4M | $261.2M | $181.4M | $189.6M | $103.3M | $74.7M | $71.0M | $60.3M | $27.9M | $12.5M | $5.9M | ||
| Liabilities And Stockholders Equity | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $719.6M | $490.8M | $540.6M | $559.6M | $198.0M | $59.6M | ||
| Liabilities | $1.61B | $1.24B | $1.22B | $1.19B | $599.8M | $605.2M | $481.7M | $110.7M | $107.3M | $66.7M | $28.5M | $13.0M | $9.5M | ||
| Common Stock Value | $0.00 | $0.00 | $82.0K | $70.0K | $69.0K | $67.0K | $58.0K | $51.0K | $44.0K | $41.0K | $39.0K | $32.0K | $4.0K | ||
| Assets Current | $951.0M | $817.0M | $732.2M | $883.9M | $856.6M | $1.30B | $851.0M | $522.4M | $269.6M | $401.7M | $450.2M | $193.4M | $55.2M | ||
| Assets | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $719.6M | $490.8M | $540.6M | $559.6M | $198.0M | $59.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0M | -$1.0M | $647.0K | -$6.6M | -$1.4M | $689.0K | -$147.0K | -$633.0K | -$5.7M | $905.0K | -$868.0K | -$174.0K | $11.0K | ||
| Accrued Liabilities Current | $265.0M | $241.0M | $196.5M | $204.7M | $145.6M | $108.5M | $83.2M | $62.5M | $62.1M | $54.6M | $24.8M | $7.6M | $4.4M | ||
| Accounts Payable Current | $31.0M | $39.0M | $42.1M | $43.3M | $17.1M | $12.9M | $12.9M | $12.3M | $8.9M | $5.4M | $2.9M | $4.9M | $1.4M | ||
| Prepaid Expense And Other Assets Current | $61.0M | $40.0M | $47.6M | $71.7M | $57.6M | $51.4M | $42.9M | $29.2M | $20.1M | $13.1M | $5.9M | $1.8M | |||
| Issuance Of Common Stock Under Equity Plan Awards Net Of Tax | $6.0M | $11.0M | $8.0M | $10.8M | $40.1M | $9.8M | $27.8M | $9.3M | $7.8M | $6.4M | |||||
| Equity Securities Fv Ni Gain Loss | -$1.1M | $397.0K | -$19.3M | -$42.1M | $170.4M | $13.4M | |||||||||
| Other Liabilities Noncurrent | $20.0M | $17.0M | $12.2M | $4.8M | $1.0M | $4.8M | $5.1M | $6.4M | $561.0K | $505.0K | $200.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $252.0M | -$35.0M | $81.0M | -$172.0M | -$416.7M | $290.1M | $320.7M | $12.5M | -$61.6M | $68.8M | |||||
| Inventory Net | $52.0M | $45.0M | $34.0M | $26.8M | $16.2M | $13.0M | $11.5M | $7.1M | $757.0K | ||||||
| Intangible Assets Net Excluding Goodwill | $176.0M | $178.0M | $166.3M | $160.1M | $130.8M | $131.1M | $129.0M | $129.2M | $141.5M | ||||||
| Goodwill | $44.0M | $44.0M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | ||||||
| Accounts Receivable Net Current | $158.0M | $122.0M | $73.4M | $40.4M | $28.4M | $23.1M | $32.8M | $12.7M | $5.2M | ||||||
| Liability Related To Sale Of Future Royalties | $1.15B | $820.0M | $862.3M | $875.4M | $351.8M | $315.4M | $0.00 | ||||||||
| Short Term Investments | $346.3M | $134.0M | $219.0M | $343.4M | $163.2M | $46.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.2M | $151.3M | $144.2M | $346.8M | $432.4M | $140.3M | $31.7M | $129.0M | $220.5M | $468.8M | $678.1M | $796.4M | $933.7M | $972.2M | $1.05B | $666.2M | $695.6M | $609.1M | $727.3M | $819.8M | $886.7M | $662.6M | $704.0M | $723.7M | $365.6M | $429.5M | $488.5M | $455.9M | $443.9M | $489.8M | $576.8M | $319.3M | $341.1M | $199.3M | $153.1M | $165.7M | ||||||
| Cash And Cash Equivalents At Carrying Value | $202.5M | $176.3M | $127.1M | $150.6M | $480.7M | $112.3M | $72.6M | $102.1M | $85.8M | $391.7M | $159.9M | $154.0M | $197.5M | $290.9M | $383.8M | $197.5M | $335.6M | $298.2M | $122.6M | $131.3M | $269.7M | $83.0M | $110.9M | $226.7M | $60.4M | $90.8M | $159.5M | $142.3M | $55.1M | $70.8M | $166.7M | $52.4M | $178.0M | $53.4M | $17.5M | $55.4M | $6.0M | $13.5M | $64.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $214.7M | $188.6M | $139.2M | $160.2M | $490.3M | $122.4M | $78.6M | $107.7M | $91.5M | $396.3M | $162.7M | $156.2M | $209.5M | $302.9M | $396.4M | $200.3M | $338.4M | $301.0M | $125.2M | $134.0M | $272.0M | $85.4M | $113.3M | $229.2M | $62.7M | |||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.7M | $3.8M | $3.0M | -$1.9M | -$940.0K | $299.0K | $839.0K | $239.0K | $549.0K | -$1.8M | -$965.0K | -$479.0K | ||||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$4.40B | -$4.22B | -$4.11B | -$3.82B | -$3.69B | -$3.56B | -$3.26B | -$3.10B | -$2.94B | -$2.63B | -$2.38B | -$2.23B | -$1.95B | -$1.88B | -$1.76B | -$1.60B | -$1.53B | -$1.55B | -$1.34B | -$1.23B | -$1.13B | -$942.5M | -$855.1M | -$802.4M | -$750.9M | -$671.7M | -$598.8M | -$459.2M | -$394.3M | -$337.4M | -$229.4M | -$190.2M | -$160.4M | -$122.3M | -$106.5M | -$92.9M | ||||||
| Property Plant And Equipment Net | $250.0M | $255.8M | $260.9M | $272.4M | $278.7M | $285.1M | $296.8M | $289.0M | $277.9M | $234.6M | $207.4M | $177.1M | $119.1M | $104.6M | $87.6M | $48.8M | $48.3M | $47.6M | $31.9M | $25.3M | $21.7M | $19.8M | $20.9M | $20.8M | $16.0M | $16.4M | $16.5M | $18.2M | $17.1M | $13.4M | $6.3M | $4.8M | $3.5M | $2.6M | $2.5M | $1.8M | ||||||
| Other Assets Noncurrent | $57.9M | $60.1M | $62.4M | $53.9M | $53.8M | $60.0M | $27.9M | $26.5M | $22.3M | $18.3M | $21.1M | $21.2M | $16.4M | $12.7M | $8.9M | $5.1M | $2.6M | $4.9M | $3.1M | $3.2M | $2.7M | $3.2M | $3.2M | $1.6M | $1.3M | $1.7M | $1.8M | $1.9M | $1.4M | $2.1M | $734.0K | $790.0K | $781.0K | $825.0K | $1.1M | $550.0K | ||||||
| Liabilities Current | $340.0M | $293.2M | $291.7M | $285.0M | $272.9M | $245.6M | $254.0M | $244.4M | $218.2M | $227.4M | $220.6M | $167.2M | $135.9M | $127.1M | $127.0M | $201.2M | $219.7M | $196.9M | $90.3M | $75.0M | $66.9M | $66.7M | $66.0M | $57.6M | $64.3M | $62.7M | $51.8M | $50.4M | $32.0M | $29.9M | $24.7M | $23.0M | $14.2M | $11.1M | $8.9M | $6.8M | ||||||
| Liabilities And Stockholders Equity | $1.19B | $1.31B | $1.31B | $1.54B | $1.62B | $1.31B | $1.24B | $1.31B | $1.38B | $1.62B | $1.32B | $1.38B | $1.48B | $1.51B | $1.60B | $1.27B | $1.31B | $1.23B | $879.9M | $958.9M | $1.01B | $765.1M | $806.0M | $817.4M | $435.0M | $497.5M | $545.8M | $515.2M | $482.0M | $524.2M | $602.1M | $343.0M | $355.8M | $210.9M | $162.6M | $172.7M | ||||||
| Liabilities | $1.17B | $1.15B | $1.16B | $1.18B | $1.19B | $1.17B | $1.21B | $1.18B | $1.16B | $1.15B | $642.6M | $587.6M | $551.1M | $540.3M | $543.2M | $602.2M | $618.5M | $624.0M | $152.7M | $139.1M | $121.0M | $102.5M | $102.1M | $93.7M | $69.5M | $68.1M | $57.3M | $59.3M | $38.1M | $34.4M | $25.4M | $23.7M | $14.7M | $11.6M | $9.5M | $7.0M | ||||||
| Common Stock Value | $96.0K | $96.0K | $94.0K | $92.0K | $92.0K | $83.0K | $72.0K | $71.0K | $71.0K | $70.0K | $70.0K | $70.0K | $68.0K | $68.0K | $67.0K | $61.0K | $60.0K | $59.0K | $58.0K | $58.0K | $57.0K | $51.0K | $50.0K | $50.0K | $42.0K | $42.0K | $42.0K | $40.0K | $39.0K | $39.0K | $39.0K | $36.0K | $36.0K | $32.0K | $30.0K | $30.0K | ||||||
| Assets Current | $643.2M | $719.8M | $699.2M | $799.6M | $964.6M | $596.0M | $599.2M | $702.1M | $766.3M | $1.01B | $678.5M | $707.5M | $846.9M | $949.5M | $1.07B | $872.0M | $906.0M | $894.3M | $613.5M | $699.4M | $786.9M | $567.5M | $604.7M | $581.6M | $390.9M | $419.8M | $444.7M | $416.8M | $411.1M | $430.2M | $460.7M | $336.5M | $350.5M | $206.7M | $158.2M | $169.6M | ||||||
| Assets | $1.19B | $1.31B | $1.31B | $1.54B | $1.62B | $1.31B | $1.24B | $1.31B | $1.38B | $1.62B | $1.32B | $1.38B | $1.48B | $1.51B | $1.60B | $1.27B | $1.31B | $1.23B | $879.9M | $958.9M | $1.01B | $765.1M | $806.0M | $817.4M | $435.0M | $497.5M | $545.8M | $515.2M | $482.0M | $524.2M | $602.1M | $343.0M | $355.8M | $210.9M | $162.6M | $172.7M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $820.0K | -$268.0K | -$341.0K | $896.0K | -$1.1M | -$431.0K | -$2.2M | -$3.1M | -$4.0M | -$10.2M | -$8.9M | -$6.6M | $54.0K | $232.0K | $56.0K | $1.0M | $1.3M | -$1.5M | -$71.0K | $255.0K | -$148.0K | -$410.0K | -$654.0K | -$946.0K | -$7.4M | -$4.2M | $231.0K | $12.0K | $252.0K | $92.0K | -$39.0K | -$209.0K | -$94.0K | -$118.0K | -$48.0K | -$46.0K | ||||||
| Accrued Liabilities Current | $220.5M | $180.8M | $173.0M | $185.0M | $154.4M | $149.1M | $178.6M | $167.7M | $144.4M | $189.1M | $170.4M | $126.4M | $109.7M | $91.1M | $82.7M | $79.7M | $71.9M | $67.7M | $69.6M | $59.3M | $49.0M | $58.5M | $55.7M | $49.3M | $54.3M | $50.1M | $42.8M | $43.5M | $24.7M | $23.6M | $20.1M | $12.7M | $8.4M | $6.8M | $5.3M | $3.2M | ||||||
| Accounts Payable Current | $40.6M | $34.2M | $47.5M | $36.0M | $59.8M | $41.0M | $33.4M | $42.1M | $59.0M | $23.5M | $34.2M | $23.7M | $15.6M | $21.8M | $15.7M | $10.9M | $9.0M | $14.4M | $13.5M | $8.7M | $12.7M | $8.2M | $10.3M | $7.6M | $9.3M | $11.9M | $8.3M | $6.6M | $7.0M | $6.0M | $4.4M | $10.2M | $5.8M | $4.2M | $3.6M | $3.5M | ||||||
| Prepaid Expense And Other Assets Current | $53.2M | $61.2M | $59.8M | $46.0M | $51.4M | $67.4M | $68.9M | $71.0M | $77.5M | $63.0M | $69.2M | $63.9M | $68.0M | $64.3M | $58.2M | $64.8M | $49.2M | $46.6M | $45.0M | $49.7M | $36.8M | $34.0M | $19.4M | $19.7M | $19.2M | $18.9M | $17.8M | $17.1M | $12.3M | $9.4M | $6.9M | $5.5M | $4.9M | $4.2M | ||||||||
| Issuance Of Common Stock Under Equity Plan Awards Net Of Tax | $2.0K | $3.9M | $157.0K | $4.1M | $4.1M | -$59.0K | $442.0K | $4.6M | -$750.0K | $1.1M | $6.0M | $1.8M | $7.7M | $12.7M | $12.8M | $19.2M | $15.5M | $904.0K | $3.8M | $3.9M | $9.2M | $13.2M | $3.6M | |||||||||||||||||||
| Equity Securities Fv Ni Gain Loss | $678.0K | -$9.0K | -$157.0K | $678.0K | -$4.0M | $3.7M | -$1.4M | $261.0K | -$334.0K | -$1.6M | -$10.2M | -$9.3M | $25.7M | -$31.0M | -$20.6M | $79.1M | -$11.5M | $95.2M | $7.7M | $1.4M | $2.2M | $9.8M | ||||||||||||||||||||
| Other Liabilities Noncurrent | $18.8M | $17.4M | $17.1M | $16.1M | $15.2M | $14.5M | $10.2M | $10.4M | $9.3M | $4.1M | $3.8M | $3.4M | $471.0K | $7.3M | $4.7M | $4.8M | $4.9M | $5.2M | $5.4M | $5.6M | $8.8M | $6.1M | $4.5M | $634.0K | $684.0K | $478.0K | $533.0K | $560.0K | $182.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$45.0M | -$97.0M | -$46.1M | -$153.4M | -$329.9M | -$135.3M | $156.5M | $126.2M | -$2.8M | |||||||||||||||||||||||||||||||||
| Inventory Net | $52.2M | $46.5M | $46.0M | $43.3M | $40.1M | $35.9M | $31.8M | $28.3M | $26.6M | $21.8M | $21.1M | $17.8M | $15.2M | $15.1M | $12.5M | $14.5M | $11.1M | $11.4M | $14.1M | $13.6M | $10.9M | $5.6M | $3.3M | $2.1M | ||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $172.9M | $174.7M | $176.5M | $164.9M | $166.2M | $165.0M | $157.3M | $158.2M | $159.2M | $158.4M | $159.2M | $160.0M | $130.9M | $131.0M | $131.0M | $131.2M | $131.3M | $129.0M | $129.0M | $129.1M | $129.1M | $130.2M | $132.8M | $137.1M | ||||||||||||||||||
| Goodwill | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | $44.4M | ||||||||||||||||||
| Accounts Receivable Net Current | $112.5M | $124.5M | $98.8M | $93.3M | $106.0M | $100.3M | $79.3M | $70.5M | $43.0M | $31.2M | $37.2M | $28.4M | $25.4M | $24.7M | $25.0M | $27.8M | $14.9M | $29.3M | $23.1M | $20.9M | $15.6M | $9.2M | $17.4M | $3.7M | ||||||||||||||||||
| Liability Related To Sale Of Future Royalties | $763.7M | $782.7M | $794.0M | $829.7M | $842.2M | $848.7M | $876.0M | $881.0M | $886.5M | $862.1M | $358.9M | $355.6M | $348.1M | $344.0M | $340.2M | $335.7M | $331.0M | $325.8M | $320.8M | |||||||||||||||||||||||
| Short Term Investments | $568.0M | $477.8M | $365.1M | $321.6M | $404.5M | $486.9M | $445.6M | $420.1M | $436.3M | $314.6M | $310.7M | $308.9M | $265.7M | $254.2M | $336.7M | $341.1M | $281.7M | $273.7M | $164.5M | $147.8M | $135.8M | $110.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $82.0M | $80.1M | $68.0M | $48.3M | $24.9M | $5.4M | $657.0K | $891.0K | ||||||
| Financing Cash Flow * | $478.0M | $399.0M | $388.0M | $501.2M | $118.6M | $600.3M | $679.3M | $336.9M | $136.3M | $138.7M | $467.6M | $185.0M | $171.0K | $89.2M |
| Investing Cash Flow * | $236.0M | -$18.0M | $168.0M | -$291.7M | -$195.4M | -$179.1M | -$13.0M | -$33.3M | $55.5M | $91.1M | -$292.4M | -$123.4M | -$47.7M | -$1.2M |
| Operating Cash Flow * | -$466.0M | -$414.0M | -$475.0M | -$380.5M | -$338.7M | -$132.2M | -$345.4M | -$290.6M | -$253.8M | -$161.0M | -$106.0M | -$44.6M | -$31.2M | -$12.5M |
| Payments To Acquire Property Plant And Equipment | $6.0M | $7.0M | $44.0M | $116.1M | $73.1M | $43.9M | $24.8M | $4.1M | $2.8M | $10.2M | $5.0M | $2.1M | $407.0K | $1.1M |
| Depreciation Depletion And Amortization | $35.0M | $36.0M | $26.0M | $18.2M | $13.2M | $12.3M | $8.5M | $19.5M | $5.8M | $3.4M | $1.4M | $684.0K | $444.0K | $313.0K |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $444.0M | $410.0M | $696.0M | $450.7M | $718.1M | $589.8M | $676.2M | $302.6M | $273.6M | $403.2M | $249.1M | $83.0M | $16.6M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$3.8M | $29.5M | -$2.7M | $8.2M | $14.3M | -$3.1M | $7.1M | $7.1M | $4.1M | $1.6M | $47.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.0M | -$2.0M | $0.00 | -$1.1M | -$1.2M | $1.1M | -$165.0K | -$472.0K | $528.0K | -$65.0K | ||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 6.0M | 11.0M | 8.0M | 10.8M | 40.1M | 89.3M | 9.8M | 27.8M | 9.3M | 7.8M | 6.4M | 736.0K | ||
| Increase Decrease In Accounts Receivable | $31.0M | $34.0M | $23.0M | $12.1M | $5.4M | -$9.8M | $20.1M | $7.6M | $5.2M | |||||
| Increase Decrease In Inventories | $6.0M | $11.0M | $7.0M | $9.7M | $3.1M | $1.3M | $4.5M | $5.3M | $757.0K | |||||
| Proceeds From Issuance Of Common Stock At Market Offering | $80.0M | $0.00 | $53.0M | $0.00 | $78.9M | $20.4M | $24.8M | $38.1M | $132.0M | $79.5M | ||||
| Increase Decrease In Accounts Payable Accrued Liabilities And Other Operating Liabilities | $24.0M | $47.0M | -$1.0M | $79.8M | $32.3M | $26.9M | $13.3M | $2.4M | -$1.2M | |||||
| Payments To Acquire Available For Sale Securities | $692.8M | $509.8M | $230.5M | $442.5M | $624.2M | $209.0M | $64.0M | |||||||
| Allocated Share Based Compensation Expense Net Of Capitalized Inventory Cost | $153.0M | $158.0M | $135.0M | $130.4M | $105.0M | $85.7M | $82.0M | $80.1M | ||||||
| Increase Decrease In Accounts Payable | $3.4M | $3.5M | $2.5M | -$2.0M | $3.2M | $237.0K | $858.0K | |||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $435.6M | $330.4M | $271.0M | $461.1M | $188.6M | $171.0K | $131.0K | |||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.0M | -$4.6M | $32.2M | $16.7M | $3.5M | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $19.9M | $22.2M | $20.2M | $20.7M | $19.6M | $18.8M | $17.2M | $14.5M | $10.2M | $2.4M | $795.0K | $191.0K | ||||||||||
| Financing Cash Flow * | $157.0K | -$58.0K | -$722.0K | $1.6M | $12.6M | $55.6M | $353.6M | $286.4M | $69.0M | $314.0K | $175.4M | $121.8M | $1.0K | |||||||||
| Investing Cash Flow * | $119.9M | $94.4M | $111.3M | -$37.4M | -$182.4M | -$95.1M | -$101.2M | -$71.0M | -$10.6M | $21.8M | -$4.1M | -$65.4M | -$15.1M | |||||||||
| Operating Cash Flow * | -$166.5M | -$190.7M | -$156.9M | -$117.5M | -$159.3M | -$95.2M | -$95.8M | -$89.5M | -$61.2M | -$44.9M | -$17.7M | -$8.3M | -$6.3M | |||||||||
| Payments To Acquire Property Plant And Equipment | $1.3M | $3.2M | $25.0M | $32.2M | $16.4M | $14.1M | $3.1M | $475.0K | $485.0K | $1.5M | $459.0K | $569.0K | $177.0K | |||||||||
| Depreciation Depletion And Amortization | $9.0M | $8.8M | $5.2M | $4.1M | $3.4M | $2.9M | $2.1M | $6.2M | $1.2M | $544.0K | $201.0K | $117.0K | $124.0K | |||||||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $136.9M | $128.8M | $191.6M | $189.0M | $224.2M | $187.6M | $140.0M | $60.3M | $65.0M | $131.4M | $62.2M | $23.5M | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $519.0K | -$9.1M | $10.7M | $15.1M | $1.4M | $5.3M | -$930.0K | $4.0M | $948.0K | $2.4M | $776.0K | |||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.4M | -$679.0K | $211.0K | -$108.0K | -$771.0K | -$623.0K | -$198.0K | $249.0K | ||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 1.8M | 12.8M | 380.0K | 3.9M | 3.6M | 1.4M | 314.0K | |||||||||||||||
| Increase Decrease In Accounts Receivable | -$10.1M | $24.9M | $2.5M | -$33.0K | $2.0M | -$3.5M | $2.9M | -$1.5M | ||||||||||||||
| Increase Decrease In Inventories | $763.0K | $2.1M | -$150.0K | $1.5M | -$474.0K | -$149.0K | $3.6M | $1.3M | ||||||||||||||
| Proceeds From Issuance Of Common Stock At Market Offering | $0.00 | $79.7M | $24.8M | $28.5M | $19.3M | $11.8M | $67.6M | |||||||||||||||
| Increase Decrease In Accounts Payable Accrued Liabilities And Other Operating Liabilities | -$48.5M | -$35.5M | -$35.5M | -$16.2M | -$23.6M | -$5.4M | -$13.1M | |||||||||||||||
| Payments To Acquire Available For Sale Securities | $285.2M | $260.7M | $260.8M | $87.5M | $118.1M | $77.3M | $88.0M | |||||||||||||||
| Allocated Share Based Compensation Expense Net Of Capitalized Inventory Cost | $39.9M | $36.9M | $32.0M | $29.4M | $24.3M | $20.2M | $20.2M | |||||||||||||||
| Increase Decrease In Accounts Payable | -$151.0K | -$1.3M | $3.0M | $2.6M | $437.0K | $2.1M | $1.3M | |||||||||||||||
| Proceeds From Issuance Of Common Stock | $330.4M | $271.0M | $314.0K | $175.4M | $128.4M | $1.0K | ||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$12.9M | -$12.6M | -$12.5M | -$1.9M | $664.0K | -$1.2M | -$332.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.83 | -$6.29 | -$8.25 | -$10.12 | -$6.70 | -$3.07 | -$7.12 | -$3.97 | -$7.12 | -$6.21 | -$3.96 | -$2.25 | -$14.87 | -$14.20 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 67.8M | 60.8M | 56.6M | 49.8M | 42.5M | 39.6M | 36.8M | 28.8M | 3.4M | 1.4M | ||||
| Common Stock Shares Outstanding | 96.6M | 92.5M | 82.3M | 70.2M | 69.3M | 66.8M | 57.8M | 50.9M | 44.2M | 41.2M | 38.9M | 31.9M | 3.8M | |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Issued | 69.3M | 66.8M | 57.8M | 50.9M | 44.2M | 41.2M | 38.9M | 31.9M | 31.9M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 98.6M | 90.5M | 73.5M | 69.9M | 67.8M | 60.8M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 98.6M | 90.5M | 73.5M | 69.9M | 67.8M | 60.8M | ||||||||
| Earnings Per Share Basic | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.81 | -$1.17 | -$1.57 | -$1.40 | -$1.52 | -$2.03 | -$2.23 | -$2.25 | -$2.33 | -$3.50 | -$2.26 | -$2.19 | -$1.08 | -$1.81 | -$2.03 | -$1.13 | $0.41 | -$2.05 | -$1.62 | -$1.96 | -$1.72 | -$1.82 | -$1.74 | -$1.06 | $0.62 | -$1.89 | -$1.87 | -$1.72 | -$1.63 | -$1.75 | -$1.64 | -$1.46 | -$1.35 | -$1.42 | -$1.03 | -$0.83 | -$0.63 | -$0.52 | -$0.50 | -$0.45 | -$0.85 | -$4.98 | -$3.48 | -$3.32 | -$2.84 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 69.9M | 69.5M | 67.9M | 67.6M | 67.1M | 60.7M | 58.0M | 57.7M | 57.5M | 53.2M | 50.3M | 49.8M | 42.5M | 42.3M | 41.8M | 39.6M | 39.0M | 39.0M | 38.3M | 35.9M | 34.0M | 31.6M | 30.1M | 21.6M | 3.6M | 3.3M | 2.9M | |||||||||||||||||||
| Common Stock Shares Outstanding | 96.4M | 96.4M | 93.9M | 92.3M | 92.1M | 83.1M | 72.2M | 71.5M | 70.7M | 70.1M | 70.0M | 69.8M | 68.0M | 67.8M | 67.4M | 60.8M | 60.4M | 59.5M | 57.7M | 57.7M | 57.3M | 50.5M | 50.1M | 49.7M | 42.5M | 42.4M | 42.3M | 40.1M | 39.0M | 39.0M | 38.8M | 36.1M | 35.6M | 31.8M | 30.1M | 30.0M | ||||||||||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||||||||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Common Stock Shares Issued | 72.2M | 71.5M | 70.7M | 70.2M | 70.1M | 70.0M | 69.8M | 68.0M | 67.8M | 67.4M | 60.8M | 60.4M | 59.5M | 57.7M | 57.7M | 57.3M | 50.5M | 50.1M | 49.7M | 42.5M | 42.4M | 42.3M | 40.1M | 39.0M | 39.0M | 38.8M | 36.1M | 35.6M | 31.8M | 30.1M | 30.0M | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 99.8M | 98.5M | 96.3M | 95.5M | 86.6M | 84.3M | 71.7M | 70.9M | 70.4M | 70.1M | 69.9M | 69.5M | 67.9M | 67.6M | 60.0M | 57.5M | 53.2M | 48.2M | 41.8M | |||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 99.8M | 98.5M | 96.3M | 95.5M | 86.6M | 84.3M | 71.7M | 70.9M | 70.4M | 70.1M | 69.9M | 69.5M | 67.9M | 67.6M | 61.1M | 57.5M | 53.2M | 49.1M | 41.8M | |||||||||||||||||||||||||||
| Earnings Per Share Basic | $-1.81 | $-1.17 | $-1.57 | $-1.40 | $-1.52 | $-2.03 | $-2.23 | $-2.25 | $-2.33 | $-3.50 | $-2.26 | $-2.19 | $-1.08 | $-1.81 | $0.42 | $-1.72 | $-1.82 | $0.63 | $-1.63 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $25.0M | $37.0M | $27.0M | $11.1M | $1.9M | $7.0M | $13.2M | $9.5M | $4.1M | $3.8M | $2.3M | $608.0K | $216.0K | $1.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $152.0M | $159.0M | $135.0M | $131.7M | $105.3M | $85.8M | $82.0M | $81.2M | $68.0M | $48.3M | $24.9M | $5.4M | ||
| Additional Paid In Capital | $4.45B | $4.21B | $3.66B | $3.14B | $3.00B | $2.77B | $2.09B | $1.64B | $1.22B | $1.00B | $816.6M | $324.1M | ||
| Other Noncash Income Expense | $2.0M | $2.0M | -$3.0M | $230.0K | -$235.0K | -$946.0K | -$2.6M | $156.0K | -$700.0K | |||||
| Stock Issued During Period Value At Market Offering | $80.0M | $53.0M | $78.9M | $20.4M | $24.8M | $38.1M | $132.0M | $79.5M | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $5.0M | $15.0M | $10.0M | $18.0M | $19.0M | $8.5M | $10.4M | $1.2M | $400.0K | $147.0K | $769.0K | $243.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $5.9M | $5.8M | $6.8M | $10.7M | $7.4M | $8.8M | $5.9M | $6.0M | $6.3M | $3.5M | $899.0K | $494.0K | $408.0K | $441.0K | $639.0K | $1.3M | $1.8M | $2.9M | $3.3M | $4.1M | $3.1M | $2.7M | $2.4M | $1.7M | $1.1M | $1.2M | $1.1M | $922.0K | $971.0K | $984.0K | $673.0K | $456.0K | $273.0K | $171.0K | $149.0K | $93.0K | $68.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $37.2M | $38.3M | $39.6M | $41.8M | $39.5M | $36.7M | $36.2M | $34.4M | $30.1M | $36.1M | $36.2M | $29.6M | $27.0M | $27.1M | $24.2M | $20.5M | $22.4M | $20.2M | $19.9M | $22.5M | $20.5M | $20.7M | $19.6M | $18.8M | |||||||||||||
| Additional Paid In Capital | $4.41B | $4.37B | $4.25B | $4.17B | $4.12B | $3.70B | $3.30B | $3.24B | $3.17B | $3.11B | $3.07B | $3.03B | $2.88B | $2.85B | $2.81B | $2.26B | $2.22B | $2.16B | $2.07B | $2.05B | $2.01B | $1.61B | $1.56B | $1.53B | $1.12B | $1.11B | $1.09B | $915.1M | $837.9M | $827.1M | $806.2M | $509.7M | $501.6M | $321.7M | $259.6M | $258.6M | |
| Other Noncash Income Expense | $1.2M | $77.0K | -$187.0K | -$35.0K | -$325.0K | -$463.0K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value At Market Offering | $79.7M | $24.8M | $28.5M | $20.4M | $5.5M | $19.3M | $15.8M | $11.8M | |||||||||||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $1.6M | $1.3M | $9.1M | $24.8M |
Most recent annual filing with the SEC: February 18, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.